ASTX727, YERVOY 5 mg/ml concentrate for solution for infusion, OPDIVO 10 mg/mL concentrate for solution for infusion.
NIBIT-ML-1
Phase 2 small_molecule active
Quick answer
ASTX727, YERVOY 5 mg/ml concentrate for solution for infusion, OPDIVO 10 mg/mL concentrate for solution for infusion. for MM and NSCLC patients resistant to anti-PD-1/PD-L1 therapy is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fondazione Telethon ETS
- Indication
- MM and NSCLC patients resistant to anti-PD-1/PD-L1 therapy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active